Pre-commercial procurement for environmentally sustainable, climate neutral and circular health and care systems
HORIZON Pre-commercial Procurement
Basic Information
- Identifier
- HORIZON-HLTH-2024-CARE-14-01
- Programme
- Ensuring access to innovative, sustainable and high-quality health care (Single stage - 2024)
- Programme Period
- 2021 - 2027
- Status
- Closed (31094503)
- Opening Date
- April 25, 2024
- Deadline
- November 26, 2024
- Deadline Model
- single-stage
- Budget
- €15,000,000
- Min Grant Amount
- €3,000,000
- Max Grant Amount
- €5,000,000
- Expected Number of Grants
- 3
- Keywords
- HORIZON-HLTH-2024-CARE-14-01HORIZON-HLTH-2024-CARE-14Environmental healthHealth care sciences and services (including hospital administration, health care financing)Healthcare system
Description
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 4 “Ensuring access to innovative, sustainable and high-quality health care”. To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing, to some of the following expected outcomes:
- Public procurers, possibly in cooperation with private ones, in the area of health and care stimulate the competitive development of market-ready, environmentally sustainable innovative solutions (materials, technologies and systems/practices). These solutions take into consideration the green deal ambitions on zero pollution, climate neutrality and circular economy, while increasing the overall sustainability of the sector.
- Procurers open up opportunities for European health and technology industry actors (including start-ups/SMEs) to bring to the market innovations that are cost-efficient, safe and proven to increase environmental sustainability while improving or at least maintaining health outcomes and access to care for patients.
- Procurers facilitate the commercialisation of environmentally sustainable innovative solutions by their successful suppliers through providing them with first customer references for the validation and first pilot deployment.
- Policymakers, health care providers and professionals, patients and carers – each in their respective areas – exchange and adopt good practices and the best solutions and technologies that the market can deliver to reduce carbon emissions and minimise waste and pollution stemming from health and care provision, in line with the Green Deal ambitions.
The healthcare sector is responsible for 4-5% of global total carbon emissions[1] contributing significantly to Europe's carbon footprint and to the generation of large amounts of plastics and other waste, including chemical waste through the discharge of pharmaceuticals and diagnostic chemicals as well as disinfectants and antimicrobial resistant pathogens into the wastewater system. Good hygiene and safety are vital in this setting however innovative solutions can help to reduce the environmental impact of the healthcare sector through the efficient use of resources, increasing circularity, and the introduction of “greener” materials, technologies and practices.
Up to now the healthcare sector has not significantly embraced the green transition. However, pressure is increasing as demonstrated by the launch of the first ever Declaration on Climate and Health[2] by the UAE COP28 presidency. The declaration calls for action and joint vision on ensuring better health outcomes, in part through the transformation of health and care systems to become climate-resilient, low-carbon, sustainable, circular and equitable. Such a transformation will contribute in the long term to improving patient care by enhancing both the sustainability and overall efficiency of health and care systems.
Pre-commercial procurement (PCP) actions target consortia of procurers with similar needs that want to procure together the development of innovative solutions for greening the health and care systems. This topic does not provide direct funding to developers, industry or research organisations to perform R&D. They will be able to respond to the call for tenders launched by consortia of procurers funded under this call. Specific guidance on PCP actions and minimum eligibility requirements can be found in General Annexes H of the Horizon Europe work programme.
As every step in health and care delivery has a role in reducing its environmental footprint, the topic can support any of the different dimensions and needs for the greening of the healthcare sector.
Proposals should target either:
- Direct and indirect footprint deriving from the provision and/or delivery of care (excluding infrastructural elements related to building, transport logistics and food footprints).
- Circularity, waste production and treatment.
- Footprint from the chain of suppliers in making and delivering products, or services.
- More efficient use of resources, decreasing the overall sector footprint while addressing the constantly increasing demand for healthcare.
Focus should be on solutions that are specific to the healthcare sector therefore proposals targeting general infrastructure (energy efficiency of buildings such cooling, heating and ventilation, vehicles, construction or refurbishment), energy supply or food and catering services do not fall within scope. Within this topic, it is possible to foresee the transfer and adaptation of solutions and/or interventions from other sectors to health and care systems. It is open both to proposals requiring improvements mainly based on one specific solution/technology field, as well as to proposals requiring end-to-end solutions that need combinations of different types of innovation.
Continuous dialogue between demand and supply side is required for the success of PCPs, therefore the effective involvement of end users (e.g. clinical teams, patients or hospital structures etc) needs to be considered in the proposal. Furthermore, to stimulate dialogue with the supply side, procurers are required to organise an open market consultation before launching the procurement and to promote the call for tenders widely across Europe to potentially interested suppliers.
Involvement of procurement decision makers is needed to ensure that end solution(s) are adopted by health and care systems increasing the societal impact of the related research activities. Therefore, procurers should declare in the proposal their interest to purchase at least one solution resulting from the PCP in case the PCP delivers successful solutions and indicate whether they will (1) procure the solution(s) as part of the PCP or (2) in a separate follow-up procurement after the PCP. In the first case, procurers can implement the project as a fast-track PCP (see general annex H) and foresee the budget to purchase at least one solution during the PCP. In the second case, the procurers must include in the proposal a deliverable that prepares the follow-up procurement to purchase successful solution(s) after the PCP.
[1] https://www.thelancet.com/action/showPdf?pii=S2542-5196%2820%2930271-0
[2] https://reliefweb.int/report/world/cop28-uae-declaration-climate-and-health
Destination & Scope
Calls for proposals under this destination are directed towards the Key Strategic Orientation KSO-D ‘Creating a more resilient, inclusive and democratic European society’ of Horizon Europe’s Strategic Plan 2021-2024. Research and innovation supported under this destination should contribute to the impact areas ‘Good health and high-quality accessible health care’ and ‘A resilient EU prepared for emerging threats’, and in particular to the following expected impact, set out in the Strategic Plan for the health cluster: ‘Health care systems provide equal access to innovative, sustainable and high-quality health care thanks to the development and uptake of safe, cost-effective and people-centred solutions, with a focus on population health, health systems resilience, as well as improved evidence-based health policies’. In addition, research and innovation supported under this destination could also contribute to the following impact areas: ‘Climate change mitigation and adaptation’, ‘High quality digital services for all’ and ‘A Competitive and secure data economy’.
Health systems are affected by limitations in sustainability and resilience, challenges which have been reinforced by the COVID-19 crisis that has also revealed inequalities in access to high-quality health care services. Our health systems need to become more effective, efficient, accessible, fiscally and environmentally sustainable, and resilient in order to cope with public health emergencies, to adapt to environmental challenges like climate change and to contribute to social justice and cohesion. Therefore, the transformation and modernisation of our health systems will be one of the biggest challenges in the economic recovery-bound future, but it will also be a time of opportunity for generating evidence, taking advantage of digital and data-driven innovation and developing more flexible and equitable health systems.
Under this destination, research and innovation aims at supporting health care systems in their transformation to ensure fair access to sustainable health care services of high quality for all citizens. Funded activities should support the development of innovative, feasible, implementable, financially sound and scalable solutions in the various dimensions of health care systems (e.g. governance, financing, human and physical resources, health service provision, and patient empowerment). Ultimately, these activities should improve governance and provide decision-makers with new evidence, methods, tools and technologies for uptake into their health care systems and supporting health care professionals and providers and allocating resources according to citizens’ health needs and preferences, while ensuring fiscal and environmental sustainability to assure those needs can be met on the long-term. Funded activities should adopt a patient-centred approach that empowers patients, promotes a culture of dialogue and openness between citizens, patients, caregivers, health care providers and other relevant stakeholders, and unleashes the potential for social innovation.
In this work programme, destination 4 will focus on the following issues:
- Accelerating the development of personalised medicine in the EU and Associated Countries, especially through a public-public cofunded partnership on personalised medicine
- Increasing access to health and care services for patients and citizens, and especially for people in vulnerable situations and at risk of discrimination
- Improving the resilience and mental wellbeing of the health and care workforce, including informal carers
- Enhancing development and uptake of research and innovation in health and care systems, including environmental transformation of the systems and contributions to the European Green Deal.
In view of increasing the impact of EU investments under Horizon Europe, the European Commission welcomes and supports cooperation between EU-funded projects to enable cross-fertilisation and other synergies. This could range from networking to joint activities such as the participation in joint workshops, the exchange of knowledge, the development and adoption of best practices, or joint communication activities. Opportunities for potential synergies exist between projects funded under the same topic but also between other projects funded under another topic, cluster or pillar of Horizon Europe (but also with ongoing projects funded under Horizon 2020). In particular, this could involve projects related to European health research infrastructures (under pillar I of Horizon Europe), the EIC strategic challenges on health and EIT-KIC Health (under pillar III of Horizon Europe), or in areas cutting across the health and other clusters (under pillar II of Horizon Europe). For instance, with cluster 2 “Culture, Creativity and Inclusive Society” such as on health economics and economic models, on cost-effectiveness, fiscal sustainability and accessibility of health care, or on adaptation of public health systems to societal challenges (climate change, environmental degradation, migration, demographic change, emerging epidemics and One Health AMR) thereby contributing to building resilience; with cluster 3 “Civil Security for Society” such as on security of health care infrastructures, incl. digital health infrastructures, health systems preparedness and response to disasters and other emergencies, and quality and safety of medicine (counterfeit and substandard medicine, illicit drugs, One Health AMR); with cluster 4 “Digital, Industry and Space” such as on cybersecurity of (public) health systems, products and infrastructures of digitalised health and care, or on health impact assessment (e.g. related to consumer products, working place innovation); with cluster 5 “Climate, Energy and Mobility”; and cluster 6 “Food, Bioeconomy, Natural Resources, Agriculture and Environment”.
Expected impacts:
Proposals for topics under this destination should set out a credible pathway to contributing to ensuring access to innovative, sustainable and high-quality health care, and more specifically to one or several of the following impacts:
- Health and social care services and systems have improved governance mechanisms and are more effective, efficient, accessible, resilient, trusted and sustainable, both fiscally and environmentally. Health promotion and disease prevention will be at their heart, by shifting from hospital-centred to community-based, people-centred and integrated health care structures and successfully embedding technological innovations that meet public health needs, while patient safety and quality of services are increased.
- Health care providers are trained and equipped with the skills and competences suited for the future needs of health care systems that are modernised, digitally transformed and equipped with innovative tools, technologies and digital solutions for health care. They save time and resources by integrating and applying innovative technologies, which better involve patients in their own care, by reorganising workflows and redistributing tasks and responsibilities throughout the health care system, and by monitoring and analysing corresponding health care activities.
- Citizens are supported to play a key role in managing their own health care, informal carers (including unpaid carers) are fully supported (e.g. by preventing overburdening and economic stress) and specific needs of more vulnerable groups are recognised and addressed. They benefit from improved access to health care services, including financial risk protection, timely access to quality essential health care services, including safe, effective, and affordable essential medicines and vaccines.
- Health policy and systems adopt a holistic approach (individuals, communities, organisations, society) for the evaluation of health outcomes and value of public health interventions, the organisation of health care, and decision-making.
The actions resulting from the calls under this destination will also create strong opportunities for synergies with the EU4Health programme and in particular to contribute to the goals under the general objective “protecting people in the Union from serious cross-border threats to health and specific objective 4 “to strengthen health systems, their resilience and resource efficiency”.
Eligibility & Conditions
General conditions
2. Eligible countries: described in Annex B of the Work Programme General Annexes
A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the Horizon Europe Programme Guide.
The specific conditions for actions with PCP/PPI procurements in section H of the General Annexes apply to grants funded under this topic.
In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.
3. Other eligibility conditions: described in Annex B of the Work Programme General Annexes.
4. Financial and operational capacity and exclusion: described in Annex C of the Work Programme General Annexes.
Award criteria, scoring and thresholds are described in Annex D of the Work Programme General Annexes.
The thresholds for each criterion will be 4 (Excellence), 4 (Impact) and 3 (Implementation). The cumulative threshold will be 12.
Submission and evaluation processes are described in Annex F of the Work Programme General Annexes and the Online Manual.
Indicative timeline for evaluation and grant agreement: described in Annex F of the Work Programme General Annexes.
The specific conditions are described in General Annex H.
PCP/PPI procurement costs are eligible.
6. Legal and financial set-up of the grants: described in Annex G of the Work Programme General Annexes.
Specific conditions
7. Specific conditions: described in the specific topic of the Work Programme.
Documents
Call documents:
Standard application form (HE PCP) - call-specific application form is available in the Submission System
Standard evaluation form (HE PCP PPI)
HE General MGA v1.0
Additional documents:
HE Main Work Programme 2023–2024 – 1. General Introduction
HE Main Work Programme 2023–2024 – 4. Health
HE Main Work Programme 2023–2024 – 13. General Annexes
HE Programme Guide
HE Framework Programme and Rules for Participation Regulation 2021/695
HE Specific Programme Decision 2021/764
EU Financial Regulation
Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment
EU Grants AGA — Annotated Model Grant Agreement
Funding & Tenders Portal Online Manual
Funding & Tenders Portal Terms and Conditions
Funding & Tenders Portal Privacy Statement
Support & Resources
Online Manual is your guide on the procedures from proposal submission to managing your grant.
Horizon Europe Programme Guide contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.
Funding & Tenders Portal FAQ – find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.
Research Enquiry Service – ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.
National Contact Points (NCPs) – get guidance, practical information and assistance on participation in Horizon Europe. There are also NCPs in many non-EU and non-associated countries (‘third-countries’).
Enterprise Europe Network – contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.
IT Helpdesk – contact the Funding & Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.
European IPR Helpdesk assists you on intellectual property issues.
CEN-CENELEC Research Helpdesk and ETSI Research Helpdesk – the European Standards Organisations advise you how to tackle standardisation in your project proposal.
The European Charter for Researchers and the Code of Conduct for their recruitment – consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.
Partner Search Services help you find a partner organisation for your proposal.
Latest Updates
We recently informed the applicants about the evaluation results for their proposals.
- Number of proposals submitted (including proposals transferred from or to other calls): 12
- Number of inadmissible proposals: 0
- Number of ineligible proposals: 3
- Number of above-threshold proposals: 4
- Total budget requested for above-threshold proposals: EUR 22,640,211.00
- Number of proposals retained for funding: 3
- Number of proposals in the reserve list: 1
- Funding threshold: 13
- Number of proposals with scores lower or equal to 15 and higher or equal to 14: 1
- Number of proposals with scores lower than 14 and higher or equal to 13: 2
- Number of proposals with scores lower than 13 and higher or equal to 12: 1
Summary of observer’s report:
Observer report on the evaluation process of three different Horizon 2024 topics: HORIZON-HLTH-2024-DISEASE-12-01 (a COFUND action), HORIZON-HLTH-2024-DISEASE-13-01 (a RIA action), and HORIZON-HLTH-2024-CARE-14-01 (a PCP action). The report evaluates the efficiency, transparency, and challenges encountered during the proposal assessment process. The observer attended remote briefings, a range of central consensus meetings, all three final panel meetings and held a number of private discussions with experts during the central week. Depending on the complexity of a topic, proposals were assessed with 4 or 5 or 6 experts. For example, the HORIZON-HLTH-2024-DISEASE-12-01 COFUND action, where only one proposal was eligible, required a thorough evaluation by six experts. This proposal was noted for its length and complexity across diverse areas of expertise. Overall, all procedures were carried out in a transparent way and briefings given were very good and clear. The quality of the documentation provided to experts beforehand was high although its complexity may have been overwhelming. As mentioned above, the complexity of the topics impacted the length of consensus meetings. For example, the consensus meetings of HORIZON-HLTH-2024-CARE-14-01 PCP actions required lengthier discussions and longer time slots should be allocated to such evaluations in the future. To increase the quality of the evaluation, a new approach to calibration was introduced to the HORIZON-HLTH-DISEASE-13-01 (RIA) topic by having one proposal discussed by all experts in addition to regular calibration meetings. While this approach brings added value to the evaluation, it should be considered to further improve the set-up to enable proper engagement. The remote briefings given to the experts before the central week worked well. For on-site evaluation, some technical issues were quickly resolved, demonstrating efficiency in handling logistical challenges. All of the moderators, experts and recorders displayed impartiality and respected confidentiality. Conflicts of interest were solved with respect for the rules. All procedures complied with the relevant existing rules. Experts suggested the need for a clearer interpretation of the call text integrated into the checklist, to help prevent potential inconsistencies. Lastly, the report calls for revisiting the criteria used to prioritise proposals with equal scores above the threshold as, for example, the current method of using gender balance among the researchers in the consortium is unpopular.
For questions, please contact the Research Enquiry Service.
Call HORIZON-HLTH-2024-CARE-14 closed on 26 November 2024. 12 proposals were submitted under topic HORIZON-HLTH-2024-CARE-14-01.
Evaluation results are expected to be communicated in February 2025.